Knollwood Investment Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.7M Hold
13,783
1.28% 14
2025
Q4
$14.8M Buy
13,783
+66
+0.5% +$63.1K 1.39% 13
2025
Q3
$10.5M Buy
13,717
+118
+0.9% +$87.8K 0.94% 25
2025
Q2
$10.6M Buy
13,599
+1,300
+11% +$1.01M 1.02% 16
2025
Q1
$10.2M Buy
12,299
+728
+6% +$606K 1.12% 16
2024
Q4
$8.93M Buy
11,571
+650
+6% +$538K 0.93% 20
2024
Q3
$9.68M Hold
10,921
1.04% 13
2024
Q2
$9.89M Buy
10,921
+2,191
+25% +$1.75M 1.1% 15
2024
Q1
$6.79M Hold
8,730
1.23% 18
2023
Q4
$5.09M Buy
+8,730
New +$5.1M 1.06% 24

Other funds holding LLY

Knollwood Investment Advisory's LLY Position: Q1 2026 in Review

Knollwood Investment Advisory held its Eli Lilly (LLY) position steady in Q1 2026 at 13,783 shares worth $12.7M. The position accounts for 1.28% of the portfolio, ranked #14.

Knollwood Investment Advisory first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $14.8M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Knollwood Investment Advisory held 13,783 shares of Eli Lilly worth $12.7M as of Q1 2026.
  • Knollwood Investment Advisory left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 1.28% of Knollwood Investment Advisory's portfolio in Q1 2026, its #14 holding.
  • Knollwood Investment Advisory first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Knollwood Investment Advisory's Eli Lilly position peaked at $14.8M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Knollwood Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.